Mark Menton

home / authors / mark-menton

Mark Menton is the General Manager at HealthSparq, the health plan business unit within Kyruus.

Articles

Health Plan Executives Like Transparency Benefits, but Say Compliance is Complex

Health Plan Executives Like Transparency Benefits, but Say Compliance is Complex

Mark Menton
December 16th 2022

Another component of the government’s Transparency in Coverage mandate and No Surprises Act legislation for health insurance plans will go into effect on January 1, 2023 for price transparency.

Read More

Building Trust Through Price Transparency

Building Trust Through Price Transparency

Mark Menton
January 24th 2022

Price transparency is a primary focus for health plans in 2022 to support rising consumer demand for improved healthcare experiences and align to federal price transparency mandates.

Read More

Latest Updated Articles

man looking at screen with gene images | ©muhammad stock.adobe.com
Published: December 10th 2024 | Updated: December 26th 2024
Next-Generation Testing Cheaper and More Effective for Guiding Lung Cancer Treatment
Pills balancing on top of each other | Image credit: James Thew - stock.adobe.com
Published: July 20th 2020 | Updated: December 26th 2024
For Better HCQ Retinopathy Guidelines, Include Prescribing Physicians
K-Cast Written Summary. Diabetes Quality Measures Have Challenges But Also Successes
Published: October 3rd 2024 | Updated: December 26th 2024
K-Cast Written Summary. Diabetes Quality Measures Have Challenges But Also Successes
K-Cast Written Summary. Key Patient Considerations for Use of Intravenous and Subcutaneous Therapies
Published: October 7th 2024 | Updated: December 26th 2024
K-Cast Written Summary. Key Patient Considerations for Use of Intravenous and Subcutaneous Therapies
K-Cast Written Summary. Optimizing the Management of Myelofibrosis
Published: November 7th 2024 | Updated: December 26th 2024
K-Cast Written Summary. Optimizing the Management of Myelofibrosis
K-Cast Written Summary. FDA-Approved Treatment for Demodex Bepharitis Shortens Treatment, Improves Quality of Life
Published: July 11th 2024 | Updated: December 26th 2024
K-Cast Written Summary. FDA-Approved Treatment for Demodex Bepharitis Shortens Treatment, Improves Quality of Life
© 2024 MJH Life Sciences

All rights reserved.